Heterogeneity in Pancreatic Cancer Fibroblasts—TGFβ as a Master Regulator?

Abstract excerpt

Pancreatic ductal adenocarcinoma is an aggressive disease for which there are very few available therapies. It is notable for its high degree of tumour complexity, with the tumour microenvironment often accounting for the majority of the tumour volume. Until recently, the biology of the stroma was poorly understood, particularly in terms of heterogeneity. Recent research, however, has shed light on the intricacy...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Pancreatic and Hepatic Oncology Research
• Share to Pancreatitis Pathology and Treatment
• Share to TGF-β signaling in diseases